Promotion of physical activity for vulnerable persons with regard to chronic inflammatory diseases: Conceptualisation, implementation and evaluation of a range of activities at the interface of the life worlds of health care, sport and leisure.

Promotion of physical activity for vulnerable persons with regard to chronic inflammatory diseases: Conceptualisation, implementation and evaluation of a range of activities at the interface of the life worlds of health care, sport and leisure. - MultiPill Exercise

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016702

Enrollment

Registered

2019-07-19

Start date

2019-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity with risk factors or already manifested disease for 2 of the following four diseases: diabetes mellitus type 2, cardio-vascular diseases, hip and knee arthrosis, overweight/obesity M15-M19 E66 E10-E14 I10-I15 I20-I25

Interventions

Group 1: The intervention includes, among other things, a detailed medical examination including a capacity diagnosis to determine individual fitness. Based on the results, the participants receive a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Arthritis: diagnosed arthritis of the hip or knee accordingto the clinical ACR- criteria, WOMAC > 15 in pain and function; diabetes: German diabetes risk-test (DRT) =57 points, HbA1c 1,2 of the age-approriate reference; obesity/adipostity: BMI = 27 und = 35

Exclusion criteria

Exclusion criteria: end-organ damage, appointment for elective joint replacement, BMI = 35, physical activity before the intevention meets more than 75% of the activity recommendations for adults

Design outcomes

Primary

Measure	Time frame
t1: 12 weeks after the start of the intervention: Effectiveness of the intervention on health benefits/ disease specific measures: cardiovascular: Procam-Score, spiroergometry; metabolic: blood lipid values, changes in weight, abdominal fat mass, oral glucose tolerance, inflammatroy mediators (CRP, IL6, cytokines); Muskolo-skeletal: WOMAC, isometric maximal force	—

Secondary

Measure	Time frame
t2: 24 weeks after the start of the intervention: Disease related measurements: physical activity (Quantity of the type of activity and quality, e.g.: intensity), affective response to physical activity, health realted quality of life (VR-12), sport specific and general self-efficacy (SES questionaire), motives for sport participation (BMZI), activity of daily living	—

Countries

Germany

Contacts

Public ContactSimone Schweda

Universitätsklinikum Tübingen, Abteilung Sportmedizin

simone.schweda@med.uni-tuebingen.de07071 - 29 86477

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026